We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality." One class of hallucinogenic substances that can produce unusual states ...

A new study has found that adults with a history of depression develop long-term physical health conditions about 30% faster than those without depression. The research, published on February 13 ...

It's time to think of depression as a 'whole body' disease, researchers say THURSDAY, Feb. 13, 2025 (HealthDay News) -- Depression hits the whole body, speeding the onset of long-term physical ills as ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator.

Exercise isn't a cure for depression, but it can encourage the release of hormones that help lift your mood. It can also boost your self-confidence and help you sleep better. (Photo Credit ...

A researcher is working on apps that he hopes will be able to identify signs of depression. The programs take and analyze photos of the eyes and face while someone uses the smartphone for other ...

"Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et ...

Languages: English That has some policy experts confused about the FDA's ability to implement efficient recalls and protect Americans from foodborne illness or public health hazards. More ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...

AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy Vraylar in treatment-resistant depression, as it waits for a decision by the FDA on the new indication.

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient clinic ...